Lu-PSMA-617: the new treatment that fights prostate cancer

Lu-PSMA-617: the new treatment that fights prostate cancer

Spread the love

Lu-PSMA-617: the new treatment that fights prostate cancer

A new class of drugs, Lu-PSMA-617, track down i prostate cancers resistant achieving good success and extending the life of patients.

This was declared by an international team of researchers including Professor Johann de Bono, Professor of Experimental Cancer Medicine at the Institute of Cancer Research, London, and Medical Oncologist Advisor at the Royal Marsden NHS Foundation Trust, and Professor Ken Herrmann, Director of the Nuclear Medicine Clinic at the University Hospital from Essen, Germany.